Literature DB >> 8967523

Effects of acute and chronic hypoxia on rat lung cyclooxygenase.

M Chida1, N F Voelkel.   

Abstract

Cyclooxygenase-2 (COX-2) is an inducible cyclooxygenase enzyme and may play an important role in the pathogenesis of lung injury and in pulmonary vascular remodeling. In this study we determined the effects of acute or chronic hypoxia on COX-2 induction and its modulation by .NO and adenosine 3'-5'-cyclic monophosphate (cAMP). Isolated perfused rat lungs were exposed to a normoxic gas mixture or a hypoxic gas mixture for 3 h. Northern blot analysis showed that 3 h of acute hypoxia were sufficient to increase COX-2 but not COX-1 transcripts in the lung. COX-2 expression induced by acute hypoxia was enhanced by an inhibitor of nitric oxide synthase, N(G)-nitro-L-arginine methyl ester, and was suppressed by sodium nitroprusside, meclofenamate, and H-7 (an inhibitor of protein kinase A and C). COX-2 expression was also enhanced by dibutyryl cAMP and iloprost, a prostacyclin analogue. In contrast, 2 wk of chronic hypobaric hypoxia did not enhance COX-2 expression in the lung, but increased COX-2 protein levels, as assessed by Western blots. We conclude that acute hypoxia induces COX-2 gene expression in rat lung and that COX-2 induction by acute hypoxia is modulated by .NO, cAMP, and cyclooxygenase products. In particular, prostacyclin produced by the lung during hypoxia or shear stress induces lung COX-2 expression via a positive feedback mechanism.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8967523     DOI: 10.1152/ajplung.1996.270.5.L872

Source DB:  PubMed          Journal:  Am J Physiol        ISSN: 0002-9513


  9 in total

1.  Effects of naproxen on the hypobaric hypoxia-induced immune changes in male rats.

Authors:  Ananda Raj Goswami; Nilotpal Mandal; Goutam Dutta; Tusharkanti Ghosh
Journal:  Eur J Appl Physiol       Date:  2012-01-21       Impact factor: 3.078

2.  Systemic oxygenation weakens the hypoxia and hypoxia inducible factor 1α-dependent and extracellular adenosine-mediated tumor protection.

Authors:  Stephen M Hatfield; Jorgen Kjaergaard; Dmitriy Lukashev; Bryan Belikoff; Taylor H Schreiber; Shalini Sethumadhavan; Robert Abbott; Phaethon Philbrook; Molly Thayer; Dai Shujia; Scott Rodig; Jeffrey L Kutok; Jin Ren; Akio Ohta; Eckhard R Podack; Barry Karger; Edwin K Jackson; Michail Sitkovsky
Journal:  J Mol Med (Berl)       Date:  2014-08-15       Impact factor: 4.599

3.  Protective effect of magnolol on lipopolysaccharide-induced acute lung injury in mice.

Authors:  Yun Feng Ni; Tao Jiang; Qing Shu Cheng; Zhong Ping Gu; Yi Fang Zhu; Zhi Pei Zhang; Jian Wang; Xiao Long Yan; Wu Ping Wang; Chang Kang Ke; Yong Han; Xiao Fei Li
Journal:  Inflammation       Date:  2012-12       Impact factor: 4.092

4.  Pulmonary prostacyclin synthase overexpression in transgenic mice protects against development of hypoxic pulmonary hypertension.

Authors:  M W Geraci; B Gao; D C Shepherd; M D Moore; J Y Westcott; K A Fagan; L A Alger; R M Tuder; N F Voelkel
Journal:  J Clin Invest       Date:  1999-06       Impact factor: 14.808

5.  Intratracheal administration of cyclooxygenase-1-transduced adipose tissue-derived stem cells ameliorates monocrotaline-induced pulmonary hypertension in rats.

Authors:  Naveen K Somanna; Philipp M Wörner; Subramanyam N Murthy; Edward A Pankey; Deborah J Schächtele; Rose-Claire St Hilaire; David Jansen; Abigail E Chaffin; Bobby D Nossaman; Eckhard U Alt; Philip J Kadowitz; Reza Izadpanah
Journal:  Am J Physiol Heart Circ Physiol       Date:  2014-08-22       Impact factor: 4.733

6.  Cyclooxygenase-2 inhibition and hypoxia-induced pulmonary hypertension: effects on pulmonary vascular remodeling and contractility.

Authors:  Laura E Fredenburgh; Jun Ma; Mark A Perrella
Journal:  Trends Cardiovasc Med       Date:  2009-02       Impact factor: 6.677

7.  Celecoxib but not the combination of celecoxib+atorvastatin prevents the development of monocrotaline-induced pulmonary hypertension in the rat.

Authors:  Zo Rakotoniaina; Pascal Guerard; Frédéric Lirussi; Luc Rochette; Monique Dumas; Françoise Goirand; Marc Bardou
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2008-06-10       Impact factor: 3.000

8.  Reciprocal actions of constrictor prostanoids and superoxide in chronic hypoxia-induced pulmonary hypertension: roles of EETs.

Authors:  Sharath Kandhi; Norah Alruwaili; Michael S Wolin; Dong Sun; An Huang
Journal:  Pulm Circ       Date:  2019-12-27       Impact factor: 3.017

9.  Increased eicosanoid levels in the Sugen/chronic hypoxia model of severe pulmonary hypertension.

Authors:  Aysar Al-Husseini; Dayanjan S Wijesinghe; Laszlo Farkas; Donatas Kraskauskas; Jennifer I Drake; Ben Van Tassel; Antonio Abbate; Charles E Chalfant; Norbert F Voelkel
Journal:  PLoS One       Date:  2015-03-18       Impact factor: 3.240

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.